Resistance to pretransplant imatinib therapy may adversely affect the outcome of allogeneic stem cell transplantation in CML [1]

M. Weisser, C. Schmid, C. Schoch, W. Hiddemann, H. J. Kolb

Publikation: Beitrag in Fachzeitschrift › Brief › Begutachtung

5 Zitate (Scopus)

Originalsprache	Englisch
Seiten (von - bis)	1017-1018
Seitenumfang	2
Fachzeitschrift	Bone Marrow Transplantation
Jahrgang	36
Ausgabenummer	11
DOIs	https://doi.org/10.1038/sj.bmt.1705172
Publikationsstatus	Veröffentlicht - Dez. 2005
Extern publiziert	Ja

Zugriff auf Dokument

@article{d47ca889bdb04ff8a91477cad95c38d5,

title = "Resistance to pretransplant imatinib therapy may adversely affect the outcome of allogeneic stem cell transplantation in CML [1]",

author = "M. Weisser and C. Schmid and C. Schoch and W. Hiddemann and Kolb, {H. J.}",

year = "2005",

month = dec,

doi = "10.1038/sj.bmt.1705172",

language = "English",

volume = "36",

pages = "1017--1018",

journal = "Bone Marrow Transplantation",

issn = "0268-3369",

publisher = "Springer Nature",

number = "11",

}

TY - JOUR

T1 - Resistance to pretransplant imatinib therapy may adversely affect the outcome of allogeneic stem cell transplantation in CML [1]

AU - Weisser, M.

AU - Schmid, C.

AU - Schoch, C.

AU - Hiddemann, W.

AU - Kolb, H. J.

PY - 2005/12

Y1 - 2005/12

UR - http://www.scopus.com/inward/record.url?scp=28544446589&partnerID=8YFLogxK

U2 - 10.1038/sj.bmt.1705172

DO - 10.1038/sj.bmt.1705172

M3 - Letter

C2 - 16184176

AN - SCOPUS:28544446589

SN - 0268-3369

VL - 36

SP - 1017

EP - 1018

JO - Bone Marrow Transplantation

JF - Bone Marrow Transplantation

IS - 11

ER -